左布诺洛尔与噻吗洛尔的比较：一项为期四年的研究。
Levobunolol compared with timolol: a four-year study.
作者信息
Geyer O, Lazar M, Novack G D, Shen D, Eto C Y
机构信息
Department of Ophthalmology, Ichilove Medical Center, Sackler School of Medicine, University of Tel Aviv, Israel.
出版信息
Br J Ophthalmol. 1988 Dec;72(12):892-6. doi: 10.1136/bjo.72.12.892.
Abstract
Fifty-one patients with raised intraocular pressure (IOP) were treated for up to four years with one of three ophthalmic solutions: 0.5% levobunolol, 1% levobunolol, or 0.5% timolol. The study was conducted as a double-masked, randomised trial in which medications were administered twice daily to both eyes. Levobunolol and timolol were equally effective in reducing overall mean IOP; reductions were greater than 8.8 mmHg in all three treatment groups. The study showed levobunolol to be as safe and effective as timolol in the long-term control of raised IOP.
摘要
51名眼压升高的患者接受了三种眼科溶液之一的治疗，为期四年：0.5%左布诺洛尔、1%左布诺洛尔或0.5%噻吗洛尔。该研究作为一项双盲随机试验进行，药物每天给双眼各使用两次。左布诺洛尔和噻吗洛尔在降低总体平均眼压方面同样有效；所有三个治疗组的眼压降低均超过8.8 mmHg。该研究表明，在长期控制眼压升高方面，左布诺洛尔与噻吗洛尔一样安全有效。
相似文献
1
Levobunolol compared with timolol: a four-year study.左布诺洛尔与噻吗洛尔的比较：一项为期四年的研究。
Br J Ophthalmol. 1988 Dec;72(12):892-6. doi: 10.1136/bjo.72.12.892.
2
Efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD compared with 0.5% levobunolol hydrochloride BID in patients with open-angle glaucoma or ocular hypertension.
Clin Ther. 1998 Nov-Dec;20(6):1170-8. doi: 10.1016/s0149-2918(98)80112-4.
3
Levobunolol. A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma. The Levobunolol Study Group (Appended).
Ophthalmology. 1985 Sep;92(9):1271-6.
4
Glaucoma treatment with once-daily levobunolol.每日一次使用左布诺洛尔治疗青光眼。
Am J Ophthalmol. 1986 Mar 15;101(3):298-304. doi: 10.1016/0002-9394(86)90823-8.
5
Efficacy and safety of once-daily levobunolol for glaucoma therapy.
Can J Ophthalmol. 1989 Feb;24(1):2-6.
6
Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group.
Ophthalmology. 1989 May;96(5):642-5.
7
Levobunolol compared with timolol for the control of elevated intraocular pressure.左旋布诺洛尔与噻吗洛尔治疗眼压升高的对照研究。
Ann Ophthalmol. 1986 Oct;18(10):289-90, 292.
8
Levobunolol compared with timolol for the long-term control of elevated intraocular pressure.
Arch Ophthalmol. 1985 Mar;103(3):379-82. doi: 10.1001/archopht.1985.01050030075025.
9
Long-term ocular hypotensive effect of levobunolol: results of a one-year study.左旋布诺洛尔的长期眼压降低作用：一项为期一年的研究结果。
Br J Ophthalmol. 1985 Aug;69(8):593-9. doi: 10.1136/bjo.69.8.593.
10
Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure.每日一次使用0.25%左布诺洛尔和0.25%噻吗洛尔治疗眼压升高的疗效评估。
Am J Ophthalmol. 1991 Jul 15;112(1):56-60. doi: 10.1016/s0002-9394(14)76213-0.
引用本文的文献
1
Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study.正常眼压性青光眼患者局部使用尼普地洛或噻吗洛尔后的视野丧失：尼普地洛-噻吗洛尔研究的亚组和亚区分析。
Jpn J Ophthalmol. 2010 Jul;54(4):278-85. doi: 10.1007/s10384-010-0815-z. Epub 2010 Aug 11.
2
Medical interventions for primary open angle glaucoma and ocular hypertension.原发性开角型青光眼和高眼压症的医学干预措施。
Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD003167. doi: 10.1002/14651858.CD003167.pub3.
3
Management of glaucoma: focus on pharmacological therapy.青光眼的治疗：聚焦于药物治疗。
Drugs Aging. 2005;22(1):1-21. doi: 10.2165/00002512-200522010-00001.
4
Pharmacological therapy for glaucoma: a review.青光眼的药物治疗：综述
Drugs. 2000 Mar;59(3):411-34. doi: 10.2165/00003495-200059030-00003.
本文引用的文献
1
Comparative evaluation of the Autofield-I, CFA-120, and Fieldmaster Model 101-PR automated perimeters.
Ophthalmology. 1980 Aug;87(8):777-84. doi: 10.1016/s0161-6420(80)35162-2.
2
Adverse reactions from timolol administration.噻吗洛尔给药引起的不良反应。
Ophthalmology. 1980 May;87(5):447-50. doi: 10.1016/s0161-6420(80)35215-9.
3
Manifest glaucoma in the aged I: occurrence nine years after a population survey.老年人中的显性青光眼I：人群调查九年后的发病率
Acta Ophthalmol (Copenh). 1981 Jun;59(3):321-31. doi: 10.1111/j.1755-3768.1981.tb02996.x.
4
Visual field decay in normal subjects and in cases of chronic glaucoma.正常受试者和慢性青光眼患者的视野衰退情况。
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980;213(4):291-8. doi: 10.1007/BF00417552.
5
The value of screening for glaucoma with tonometry.眼压测量法筛查青光眼的价值。
Surv Ophthalmol. 1983 Nov-Dec;28(3):194-205. doi: 10.1016/0039-6257(83)90097-8.
6
Topical epinephrine in glaucoma suspects.
Am J Ophthalmol. 1966 Aug;62(2):272-7. doi: 10.1016/0002-9394(66)91483-8.
7
Levobunolol compared with timolol for the control of elevated intraocular pressure.左旋布诺洛尔与噻吗洛尔治疗眼压升高的对照研究。
Ann Ophthalmol. 1986 Oct;18(10):289-90, 292.
8
A clinical trial of timolol and epinephrine in the treatment of primary open-angle glaucoma.噻吗洛尔与肾上腺素治疗原发性开角型青光眼的临床试验。
Ophthalmology. 1988 Feb;95(2):247-51. doi: 10.1016/s0161-6420(88)33205-7.
9
Methodologic differences and measurement of cup-disc ratio: an epidemiologic assessment.
Arch Ophthalmol. 1976 Jul;94(7):1101-5. doi: 10.1001/archopht.1976.03910040021004.
10
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.需要对每位患者进行长期观察的随机临床试验的设计与分析。II. 分析与示例。
Br J Cancer. 1977 Jan;35(1):1-39. doi: 10.1038/bjc.1977.1.
Zotero 插件